NorthWest Biotherapeutics Inc (NWBO)

[eagle8]

meirluc,

You wrote :

I believe that only 9 IDH mutants were identified in this 331 patient trial.

.

How did you come to that?
This would mean that 322 patients in this trial would have the mesenchymal (maybe a few classical?) identity.

Only 9 IDH-mutants ( neural, proneural maybe some classical) seems very small to me.
We know that about 48% of all tumors is IDH wild type ( mesenchymal).
So the ratio should be different.

Thanks for an answer.
GLTU